Bommer C - Search Results

1

Efficacy and safety of P₁₁-4 for the treatment of periodontal defects in dogs.

Bommer C, Waller T, Hilbe M, Wiedemeier D, Meyer N, Mathes S, Jung R. Bommer C, et al. Clin Oral Investig. 2022 Mar;26(3):3151-3166. doi: 10.1007/s00784-021-04297-6. Epub 2022 Jan 10. Clin Oral Investig. 2022. PMID: 35006293 Free PMC article.

2

Randomised clinical trial investigating self-assembling peptide P₁₁-4 in the treatment of early caries.

Bröseler F, Tietmann C, Bommer C, Drechsel T, Heinzel-Gutenbrunner M, Jepsen S. Bröseler F, et al. Among authors: bommer c. Clin Oral Investig. 2020 Jan;24(1):123-132. doi: 10.1007/s00784-019-02901-4. Epub 2019 Apr 29. Clin Oral Investig. 2020. PMID: 31037343 Clinical Trial.

3

Efficacy of P₁₁-4 for the treatment of initial buccal caries: a randomized clinical trial.

Sedlakova Kondelova P, Mannaa A, Bommer C, Abdelaziz M, Daeniker L, di Bella E, Krejci I. Sedlakova Kondelova P, et al. Among authors: bommer c. Sci Rep. 2020 Nov 19;10(1):20211. doi: 10.1038/s41598-020-77057-3. Sci Rep. 2020. PMID: 33214593 Free PMC article. Clinical Trial.

4

Randomized Clinical Trial investigating Self-Assembling Peptide P₁₁-4 for Treatment of Early Occlusal Caries.

Doberdoli D, Bommer C, Begzati A, Haliti F, Heinzel-Gutenbrunner M, Juric H. Doberdoli D, et al. Among authors: bommer c. Sci Rep. 2020 Mar 6;10(1):4195. doi: 10.1038/s41598-020-60815-8. Sci Rep. 2020. PMID: 32144336 Free PMC article. Clinical Trial.

5

Hydroxyapatite and Self-Assembling Peptide Matrix for Non-Oxidizing Tooth Whitening.

Bommer C, Flessa HP, Xu X, Kunzelmann KH. Bommer C, et al. J Clin Dent. 2018 Jun;29(2):57-63. J Clin Dent. 2018. PMID: 30211992

6

Self-assembling peptide matrix for treatment of dentin hypersensitivity: A randomized controlled clinical trial.

Schlee M, Rathe F, Bommer C, Bröseler F, Kind L. Schlee M, et al. Among authors: bommer c. J Periodontol. 2018 Jun;89(6):653-660. doi: 10.1002/JPER.17-0429. Epub 2018 May 16. J Periodontol. 2018. PMID: 29520816 Clinical Trial.

7

Maintenance Therapy with Aromatase Inhibitor in epithelial Ovarian Cancer (MATAO): study protocol of a randomized double-blinded placebo-controlled multi-center phase III Trial.

McLaughlin PMJ, Klar M, Zwimpfer TA, Dutilh G, Vetter M, Marth C, du Bois A, Schade-Brittinger C, Reuss A, Bommer C, Kurzeder C, Heinzelmann-Schwarz V. McLaughlin PMJ, et al. Among authors: bommer c. BMC Cancer. 2022 May 6;22(1):508. doi: 10.1186/s12885-022-09555-8. BMC Cancer. 2022. PMID: 35524184 Free PMC article.

8

Cost-utility analysis of risk-reducing strategies to prevent breast and ovarian cancer in BRCA-mutation carriers in Switzerland.

Bommer C, Lupatsch J, Bürki N, Schwenkglenks M. Bommer C, et al. Eur J Health Econ. 2022 Jul;23(5):807-821. doi: 10.1007/s10198-021-01396-9. Epub 2021 Nov 12. Eur J Health Econ. 2022. PMID: 34767113 Free PMC article.

9

The prevalence of cardiovascular disease risk factors among adults living in extreme poverty.

Geldsetzer P, Tisdale RL, Stehr L, Michalik F, Lemp J, Aryal KK, Damasceno A, Houehanou C, Jørgensen JMA, Lunet N, Mayige M, Saeedi Moghaddam S, Mwangi KJ, Bommer C, Marcus ME, Theilmann M, Ebert C, Atun R, Davies JI, Flood D, Manne-Goehler J, Seiglie J, Bärnighausen T, Vollmer S. Geldsetzer P, et al. Among authors: bommer c. Nat Hum Behav. 2024 Mar 13. doi: 10.1038/s41562-024-01840-9. Online ahead of print. Nat Hum Behav. 2024. PMID: 38480824

10

Quasi-experimental evaluation of a nationwide diabetes prevention programme.

Lemp JM, Bommer C, Xie M, Michalik F, Jani A, Davies JI, Bärnighausen T, Vollmer S, Geldsetzer P. Lemp JM, et al. Among authors: bommer c. Nature. 2023 Dec;624(7990):138-144. doi: 10.1038/s41586-023-06756-4. Epub 2023 Nov 15. Nature. 2023. PMID: 37968391

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

47 results

Search Page